Bromfenac Ophthalmic Solution Articles

ISTA Pharma accepts $500 million bid from Bausch & Lomb; settles royalty dispute

27 March 2012

Mylan debuts first generic of Xibrom ophthalmic solution and Risperidal, as well as Amrix which Watson also debuts

17 May 2011

ISTA Pharma accepts subpoena on Xibrom promotion

14 April 2008

Once-daily Xibrom effective in Ph III study

19 February 2007

ISTA to debut Xibrom in 2nd-qtr 2005

4 April 2005

ISTA's NDA for Xibrom to be reviewed by FDA

2 August 2004

ISTA's Xibrom on track for US approval

31 May 2004

Positive Ph III data for ISTA's Xibrom

15 March 2004

Showing 1-8 of 8 articles

Go to beginning

Previous

1

Next

Go to end